AstraZeneca (AZNN MM)

121

Analysis

Health Care • United Kingdom

AstraZeneca is a multinational pharmaceutical and biotechnology company that researches, develops, and manufactures prescription medicines. The company focuses on core therapeutic areas including oncology, cardiovascular, renal and metabolic diseases, respiratory and immunology, and rare diseases. It was founded in 1999 and is headquartered in Cambridge, UK.

Refresh

bullish•AstraZeneca

•09 Aug 2026 14:48

Primer: AstraZeneca (AZNN MM) - Aug 2026

AstraZeneca is a global biopharmaceutical company with a strong focus on specialty medicines in oncology, rare diseases, and...

αSK Primers

100 Views

bullish•AstraZeneca

•23 Sep 2025 10:44

Primer: AstraZeneca PLC (AZN LN) - Sep 2025

AstraZeneca is a global biopharmaceutical powerhouse, strongly positioned for sustained growth driven by its leadership in Oncology and...

αSK Primers

140 Views

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00